Related Experiment Video
Updated: Dec 24, 2025

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
[Benign prostatic hyperplasia : New and treatment-relevant aspects from the DGU guidelines]
1Klinik für Urologie, Asklepios Westklinikum Rissen, Suurheid 20, 22559, Hamburg, Deutschland. t.bach@asklepios.com.
Diagnosing and treating lower urinary tract symptoms (LUTS) from benign prostatic enlargement requires a tailored approach. New minimally invasive procedures offer improved quality of life and preserve sexual function.
Area of Science:
- Urology
- Men's Health
Background:
- Lower urinary tract symptoms (LUTS) due to benign prostatic enlargement are common in urological practice.
- A targeted, resource-saving diagnostic and treatment approach is essential for effective patient management.
Purpose of the Study:
- To outline a rational baseline work-up for diagnosing LUTS secondary to benign prostatic enlargement.
- To review current and emerging treatment options, emphasizing minimally invasive procedures and personalized care.
Main Methods:
- Review of diagnostic strategies for benign prostatic enlargement.
- Analysis of conservative management (lifestyle modification, watchful waiting) and surgical interventions.
- Evaluation of novel minimally invasive and non-ablative procedures.
Main Results:
- Lifestyle modifications and simple measures can significantly improve quality of life.
- Laser procedures, TUR-P, and open prostatectomy are established surgical options.
- New minimally invasive procedures (PAE, Rezum™, Aquabeam®, iTind®, Urolift®) offer alternatives with potential to preserve sexual function.
Conclusions:
- Individualized risk assessment and comprehensive counseling on all treatment options are crucial.
- A personalized approach, akin to oncological treatment, will become standard for benign prostatic syndrome.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Urinary Tract Calculi III: Medical Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

